Cite
MLA Citation
Talha Badar et al.. “Sequencing of novel agents in relapsed/refractory B‐cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia.” Cancer, vol. 127, no. 7, 2021, pp. 1039–1048. http://access.bl.uk/ark:/81055/vdc_100127439253.0x00005f